Stanker James H
Insider CIK 1681718 · PCSA Chief Financial Officer · GVP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2024-07-10 | 2024-08-02 | 282 | $1.71 | $482 | 6,482 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2024-07-10 | 2024-08-02 | 644 | — | $0 | 6,764 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 3,077 | — | $0 | 26,470 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 2,307 | — | $0 | 28,777 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 385 | — | $0 | 29,547 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2024-06-28 | 2024-08-02 | 385 | — | $0 | 29,162 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2024-04-05 | 2024-08-02 | 518 | $2.79 | $1.4K | 6,120 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2024-04-05 | 2024-08-02 | 1,675 | — | $0 | 6,638 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise deriv | 2024-01-01 | 2024-04-12 | 1,675 | — | $0 | 24,037 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2024-01-01 | 2024-04-12 | 518 | $2.79 | $1.4K | 6,120 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2024-01-01 | 2024-04-12 | 1,675 | — | $0 | 6,638 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-10-12 | 2023-10-12 | 15,000 | $0.33 | $5.0K | 99,250 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-10-10 | 2023-10-10 | 22,500 | $0.24 | $5.4K | 84,250 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2023-02-09 | 2023-02-10 | 12,500 | $0.80 | $10.0K | 61,750 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2023-01-01 | 2023-01-04 | 96,150 | — | $0 | 518,431 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2023-01-01 | 2023-01-04 | 69,667 | — | $0 | 422,281 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-12-31 | 2023-01-04 | 12,951 | — | $0 | 352,614 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-09-30 | 2022-10-05 | 12,950 | — | $0 | 339,663 | SEC↗ |
| PCSA Processa Pharmaceuticals, | M Exercise | 2022-08-05 | 2022-08-09 | 7,601 | — | $0 | 51,712 | SEC↗ |
| PCSA Processa Pharmaceuticals, | F Tax w/h | 2022-08-05 | 2022-08-09 | 2,462 | $3.17 | $7.8K | 49,250 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-06-30 | 2022-10-03 | 23,947 | — | $0 | 326,713 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-06-30 | 2022-07-05 | 23,947 | — | $0 | 326,713 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-04-01 | 2022-04-11 | 247,841 | — | $0 | 302,766 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2022-03-31 | 2022-04-04 | 10,715 | — | $0 | 37,781 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-12-31 | 2022-01-04 | 6,722 | — | $0 | 6,722 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-12-31 | 2022-01-06 | 6,722 | — | $0 | 22,780 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-11-01 | 2022-04-04 | 4,286 | — | $0 | 27,066 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-09-30 | 2022-01-06 | 6,024 | — | $0 | 16,058 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-09-30 | 2021-10-04 | 6,024 | — | $0 | 6,024 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award | 2021-08-05 | 2021-08-09 | 7,601 | — | $0 | 44,111 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-07-08 | 2021-07-09 | 8,572 | — | $0 | 8,572 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-07-08 | 2021-07-09 | 12,858 | — | $0 | 12,858 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-07-08 | 2021-07-09 | 1,907 | — | $0 | 10,034 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2021-06-21 | 2021-06-22 | 1,000 | $6.81 | $6.8K | 36,510 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2021-06-08 | 2021-06-10 | 8,127 | — | $0 | 8,127 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2020-10-01 | 2020-10-05 | 6,000 | $2.10 | $12.6K | 47,248 | SEC↗ |
| PCSA Processa Pharmaceuticals, | P Buy | 2020-10-01 | 2020-10-05 | 6,000 | $4.00 | $24.0K | 47,248 | SEC↗ |
| GVP GSE SYSTEMS INC | A Award | 2019-06-11 | 2019-06-12 | 25,316 | — | $0 | 48,118 | SEC↗ |
| GVP GSE SYSTEMS INC | A Award | 2018-06-12 | 2018-06-13 | 7,911 | — | $0 | 22,802 | SEC↗ |
| GVP GSE SYSTEMS INC | A Award | 2017-06-12 | 2017-06-14 | 1,923 | — | $0 | 7,539 | SEC↗ |
| GVP GSE SYSTEMS INC | A Award | 2017-06-12 | 2017-06-14 | 7,352 | — | $0 | 14,891 | SEC↗ |
| GVP GSE SYSTEMS INC | A Award | 2016-12-08 | 2016-12-12 | 5,616 | — | $0 | 5,616 | SEC↗ |